EGFR and lung adenocarcinoma: Lung adenocarcinoma cell lines HCC827 and PC-9 carrying an activating small in-frame deletion in exon 19 of EGFR (EGFR 19del) showed sensitivity to gefitinib (Supplemental Figure S1A, S1B).